Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Method to dynamically tune precision resistance
Glycosyltransferase promoter
Imaging device, method and computer readable medium
Distributed image acquisition, storage, and backup system
Summarization of short comments
Method and system for checking citations
Methods and compositions for wound healing
  Randomly Featured Patents
Small piezoelectric air pumps with unobstructed airflow
Process for preparing platinum catalyst
Method for atomic layer deposition (ALD) of silicon oxide film
Portable support handle for aiding entry into and exit out of an automobile
Iron golf club heads, iron golf clubs and golf club evaluating method
Catalyst and use thereof
Excess flow shutoff
Antistatic fibers and methods for making the same
Providing an answer to a question left unanswered in an electronic forum
Senescent cell derived inhibitors of DNA synthesis